Company Update (NYSE:JNJ): CEO and Director of Huntsman Cancer Institute Dr. Mary Beckerle Joins Johnson & Johnson Board of Directors

[PR Newswire] – NEW BRUNSWICK, N.J., June 9, 2015 /PRNewswire/ — Johnson & Johnson (JNJ) announced today that its Board of Directors has appointed Mary Beckerle, Ph.D., Chief Executive Officer and Director of . . . → Read More: Company Update (NYSE:JNJ): CEO and Director of Huntsman Cancer Institute Dr. Mary Beckerle Joins Johnson & Johnson Board of Directors Similar Articles: Market Update: Johnson & Johnson (NYSE:JNJ) – Johnson & Johnson Announces Acceptance of Binding Offer From Cardinal Health To Acquire Cordis Market Update: The Procter & Gamble Company (NYSE:PG) – Strong dollar squeezes company earnings Stock Update (NYSE:ORCL): Oracle names Leon Panetta to board of directors